Bruce Booth is a partner and focuses on the discovery and development of novel medicines and therapeutic platforms.

Bruce is currently chairman of AvroBio (NASDAQ:AVRO), Kymera Therapeutics, Hotspot Therapeutics, Nimbus Therapeutics, Rodin Therapeutics, and Unum Therapeutics (NASDAQ:UMRX), and also serves on the boards of Lysosomal Therapeutics and Magenta Therapeutics (NASDAQ:MGTA). He previously served on the boards of past Atlas companies Avila (acquired by Celgene), Padlock (acquired by BMS), Prestwick (acquired by Biovail), Stromedix (acquired by Biogen), Zafgen (NASDAQ:ZFGN), miRagen Therapeutics (NASDAQ:MGEN), and a number of other ventures.

Bruce serves as an advisor in various capacities to UCB, Takeda, and the Gates Foundation. He also serves on the boards of the National Venture Capital Association, the Pennsylvania State Research Foundation, and New England Disabled Sports, a charity dedicated to adaptive sports. Bruce blogs about biotech and venture capital topics at LifeSciVC.com, which is syndicated on Forbes.

Prior to joining Atlas in 2005, Bruce was a consultant at McKinsey & Company, as well as an investor with Caxton Health Holdings. As a British Marshall Scholar, Bruce received a D.Phil. (PhD) in molecular immunology from Oxford University. He received a BS in biochemistry, summa cum laude, from The Pennsylvania State University.

Bruce enjoys running, skiing, hiking, and fly fishing. He lives in Wellesley, MA with his wife and three wonderful kids.

Eric J. Barron began his tenure as the 18th president of The Pennsylvania State University on May 12, 2014. Previously, Barron served as president of Florida State. He has more than 35 years of leadership experience in academic administration, education, research and public service, as well as a track record as a talented manager of fiscal policy within large and complex institutions.

In 2017, Barron was named the chairman of the Commission on Economic and Community Engagement (CECE) for the Association of Public Land-grant Universities (APLU). He also serves on the Board of Directors for APLU, Kish Bancorp, Inc., the Board of Trustees for University Corporation for Atmospheric Research (UCAR), and Universities Research Association (URA). He is also a member of the Knight Commission and the College Football Playoff Board of Managers.

Barron spent the first 20 years of his career at Penn State, serving as dean of the College of Earth and Mineral Sciences from 2002 to 2006, and as founding director of the Earth System Science Center, one of the first major initiatives focused on the total study of Earth as a system. In 1999, he was named Distinguished Professor of Geosciences at Penn State.

An accomplished scientist with a long background in atmospheric research, Barron was the director of the National Center for Atmospheric Research (NCAR) and dean of the Jackson School of Geosciences at the University of Texas at Austin. Over the decades, Barron has lent his significant expertise in the areas of atmospheric science and the geosciences to many national committees and federal agencies, including nearly 20 years of service as the chair of multiple National Research Council committees and boards.

Barron earned a B.S. in geology at Florida State and his M.S. and Ph.D. in oceanography at the University of Miami.

Anna Mason is a Partner on Revolution’s Rise of the Rest Seed Fund. In this capacity, she leads the investment process for select deals in the fund across a variety of industries including the fund’s investments into Summersalt (St. Louis, MO), Pryon (Raleigh, NC), Stord (Atlanta, GA), Dispatch (Minneapolis, MN), and Collective Retreats (Denver, CO). Anna also leads strategy and execution for the Rise of the Rest Network and Platform, including the annual Rise of the Rest Road Trip and annual Network Summit. Her passion for this work is centered around two core beliefs: investing in startups sits at the intersection of realism and optimism; Rise of the Rest is a platform that helps us see the country through the eyes of the entrepreneurs who are reimagining its future.

Anna brings over 10 years of experience in finance, startup operations, and venture community programming to Revolution. Prior to joining Revolution, she co-founded a fitness-community app that was acquired by Beachbody in 2015. Before that, she began her career on Wall Street, where she spent seven years as a distressed bond and private equity trader, most recently as a Vice President at The Seaport Group.

Given her passion for helping early stage startups, since November 2015 Anna has volunteered as the Co-Director of the Washington Chapter of The Vinetta Project, a North-American organization that helps early-stage female founders in tech access capital and network connections. She is also on the advisory board of BEACON DC, a community-led campaign to make Washington, D.C. one of the most influential and supportive cities in the country for women entrepreneurs.

Anna received her BA in Government from Harvard College and her MBA from the NYU Stern School of Business. Anna is also a certified health coach. She serves on the Board of Trustees of the National Children’s Museum in Washington, D.C.

Laura is a financial advisor who specializes in executive financial planning and career transitions. Prior to her role as an asset manager and advisor, she was a Senior Human Resource Executive for a Fortune 500 company and brings over 25 years of experience advising leaders on business strategy and mitigating risk. Laura holds a Masters in Business Administration from the University of Pittsburgh Katz School of Business and is a Certified Executive Coach.

In addition to her career, Laura is actively involved in the community. She serves on the St. Clair Hospital Board of Directors and is board chair of Strong Women Strong Girls, a multi-generational mentoring program that empowers girls in under-resourced communities. Laura is co-founder of the Pittsburgh Women's Alliance which is comprised of over 80 women serving organizations committed to making Pittsburgh the foremost region for diverse, professional women advance and thrive.

Priya Amin holds an MBA from the University of Arizona, and worked as a product and brand manager at corporations such as IBM and Nestle. In 2012, she left her high powered career to be home with her two boys.

After successfully launching and running a marketing consulting firm called ROKI in 2014, she began looking for ways to continue fostering opportunities for professional advancement among women. She launched Flexable, LLC in 2016 with her partner Jessica Strong, and was accepted to the 16th cohort of the AlphaLab Accelerator program.

Flexable has gained regional and national attention for providing innovative childcare solutions, most notably on-site childcare at offices and events, in order to drive attendance, inclusivity and productivity at work.

Rachel Herder is the Director of the Penn State Law Intellectual Property (IP) Clinic and an Asst. Prof. of Clinical Law. The IP Clinic is powered by amazing Penn State Law students and provides free legal services to Pennsylvania small businesses and startups, including: patent prosecution and searching; trademark clearance and registration; university licensing, copyright counseling, trade secret counseling, and general IP advice.

Before coming to Penn State, Rachel practiced at Wilson Sonsini Goodrich & Rosati, in the firm’s patents and innovation practice in Silicon Valley and Boston. She advised startup life science clients on various aspects of intellectual property law, including patent prosecution and related business strategies especially in the fields of genome editing and gene diagnostics. Rachel holds her Ph.D. in Molecular, Cellular, Developmental Biology & Genetics and J.D. from the University of Minnesota.

Ellen M. Saksen is CEO and CoFounder of Go Jane Go, the only community and software tool for women who travel for business. Ellen has over 20 years of product development and brand marketing experience in the consumer packaged goods, natural products, and software industries, which required global travel resulting in the creation of Go Jane Go. While at Tom’s of Maine, a leading natural products company, and Colgate-Palmolive, Ellen built new oral care brands and line extensions you can find on-shelf today and drove the entire development of the innovation portfolio for the all-new Body Care line at Tom’s.

An entrepreneur, Ellen has expertise building brands from scratch using lean startup methods and is an alumna of the AlphaLab Accelerator Program, one of the top programs in the country, and is also Cofounder of MamaSnacks. Ellen holds a Master’s in Business Administration from the Katz Graduate School of Business at the University of Pittsburgh, a Bachelor of Arts in German from Bates College, and completed a year-long Praktikum in Germanistik at Ludwig Maximilian Universitaet, Muenchen. Ellen lives in Pittsburgh with her two small children.

Teresa Whalen is the CEO of CytoAgents, Inc, a biotechnology company dedicated to reducing inflammation by targeting the immune system. CytoAgents’ lead candidate has an FDA accepted Investigational New Drug Application for the indication of Influenza and is preparing to initiate Phase 1 Human Clinical Trials.

Prior to CytoAgents, Teresa had a distinguished 20-year career in the healthcare information technology sector. Teresa has been involved with launching multiple successful beta solutions to the healthcare marketplace with roles spanning the spectrum of sales leadership, development of go-to-market strategies, product development, and managing strategic relationships.

Teresa is a Registered Pharmacist and an investor in the Next Act Fund, a fund dedicated to investing in early stage, women led innovative companies.

Aniyia Williams is a creator, inventor and tech changemaker. She serves as Executive Director of Black & Brown Founders, which provides vital resources to Black and Latinx entrepreneurs building tech companies with limited capital. She is also co-founder of Zebras Unite, an entrepreneur-led movement focused on creating a more ethical and sustainable startup ecosystem. Aniyia previously founded and led the fashion tech company, Tinsel, which created the world’s first audio necklace—earphones that double as a beautiful piece of jewelry—designed in response to the lack of electronics developed with women in mind. Before becoming an entrepreneur, Aniyia has held roles in marketing, business development and nonprofit fundraising. She also a background in the arts as a classically-trained opera singer. Aniyia studied Music, Business and Italian at Penn State Berks and University Park, graduating with honors in Fall 2007.

Jonathan is a Partner in the Reed Smith's Global Corporate Group in Philadelphia, PA. Jonathan advises companies, funds and significant individuals regarding venture capital and growth equity transactions, mergers and acquisitions, joint ventures, private equity transactions, equity and debt offerings, corporate governance issues and general corporate law. In his practice, Jonathan regularly counsels clients focused in the healthcare, life sciences, financial services, energy and media and technology industries, among others. Jonathan is a 2002 graduate of the Penn State – University Park Smeal College of Business. He received his Juris Doctorate, with honors, from Rutgers, The State University of New Jersey School of Law. He also holds his Masters of Business Administration from Temple University and Ecole Nationale des Ponts et Chaussées.

Derek Bowen, Vice President, Head of Business Development & Strategy @ Blackfynn, Inc. – Blackfynn is dedicated to further understanding and ultimately delivering effective, disease modifying therapeutics to patients in need impacted by neurological disease(s). Blackfynn’s unique access to data, experts and proprietary platform are beginning to establish data models across disease areas such as Parkinson’s, Dementia, Huntington’s, ALS, etc. Derek leads activities across strategy, finance and operations, and business development to establish collaborations across industry, foundations, advocacy and academia in line with overall corporate strategy and mission of Blackfynn.

Prior to Blackfynn, Derek was Director, Transaction Advisory and Investment Management within the Worldwide Business Development unit of GSK. In role his efforts included leading a focus on increased capital and resource commitment toward innovation as well as supporting traditional business development transactions including licensing, divestment and M&A activities. While at GSK, the Investment Management unit significantly increased capital and resource allocation to leading investment vehicles as well as innovative, strategic collaboration partners establishing a portfolio in excess of $1.5B, generating positive cash flows to the corporate balance sheet and improved engagement across the venture and financial communities. Prior to GSK, Derek was an Associate at DuPont Capital Management, a $30B+ institutional investor. As a member of the Private Markets Group, Derek supported private equity and venture investments, fundraising and client engagement efforts. Derek holds a BS from Lehigh University.

Anna Mason is a Partner on Revolution’s Rise of the Rest Seed Fund. In this capacity, she leads the investment process for select deals in the fund across a variety of industries including the fund’s investments into Summersalt (St. Louis, MO), Pryon (Raleigh, NC), Stord (Atlanta, GA), Dispatch (Minneapolis, MN), and Collective Retreats (Denver, CO). Anna also leads strategy and execution for the Rise of the Rest Network and Platform, including the annual Rise of the Rest Road Trip and annual Network Summit. Her passion for this work is centered around two core beliefs: investing in startups sits at the intersection of realism and optimism; Rise of the Rest is a platform that helps us see the country through the eyes of the entrepreneurs who are reimagining its future.

Anna brings over 10 years of experience in finance, startup operations, and venture community programming to Revolution. Prior to joining Revolution, she co-founded a fitness-community app that was acquired by Beachbody in 2015. Before that, she began her career on Wall Street, where she spent seven years as a distressed bond and private equity trader, most recently as a Vice President at The Seaport Group.

Given her passion for helping early stage startups, since November 2015 Anna has volunteered as the Co-Director of the Washington Chapter of The Vinetta Project, a North-American organization that helps early-stage female founders in tech access capital and network connections. She is also on the advisory board of BEACON DC, a community-led campaign to make Washington, D.C. one of the most influential and supportive cities in the country for women entrepreneurs.

Anna received her BA in Government from Harvard College and her MBA from the NYU Stern School of Business. Anna is also a certified health coach. She serves on the Board of Trustees of the National Children’s Museum in Washington, D.C.

Matt Rhodes is the Founder and Managing Director of 1855 Capital, a State College based Venture Capital firm. Matt Rhodes comes to this role from a background as a senior executive with experience ranging from start-up funding and management to leading a $1B+ semiconductor business. He has a track record of leading product development teams and business organizations to profitable, market winning positions in hyper-competitive environments.

Matt garnered broad business experience as President of Conexant Systems, a then publicly-owned communication semiconductor solutions provider, where Matt managed an organization of over 2,000 employees, including Sales, Marketing, Engineering and Business Development. Subsequently, he was CEO of Teranetics, a 1st tier VC-backed bay area start-up focused on high-speed communication semiconductors. As CEO, he raised two rounds of funding totaling $45 Million and grew the company to more than 70 employees and establishing international presence. He also secured 1st tier design wins for the company’s products, establishing Teranetics as the clear leader in the space.

Matt holds a B.S in Physics from Penn State University, an MSEE from Lehigh University, and an MBA from UCLA.

Taylor Whitman is a Managing Director at Concord Health Partners, a healthcare focused investment firm. He joined in 2018 and is responsible for originating, underwrting and monitoring portfolio investments. He serves on the board of Flexwise Health, Inc. and Mivi Neurosciences, Inc.

Mr. Whitman was a Partner at Three Ocean Partners, a New York based Merchant Bank. He was responsible for day to day firm operations as well as sourcing and execution of Middle-Market transactions across the firm’s direct investment and M&A platforms.

Prior to Three Ocean Partners, Mr. Whitman was a senior banker at the cross-border focused boutique M&A advisory firm, BDA Partners. He led the firm’s efforts in sourcing and executing advisory assignments in the Healthcare sector for a broad group of Corporate and Private Equity clients, while managing day to day operations of the New York office.

Mr. Whitman began his career in finance as an Analyst at Citigroup Venture Capital Equity Partners (nka Court Square Capital Partners), a $2.5 billion multi-sector private equity firm.

He has a Bachelor of Arts degree from the Carroll School of Management at Boston College.

Matt is an attorney with extensive experience advising investors, companies and executive teams across all stages of the corporate lifecycle, with a specialization in guiding clients through important early-stage transactions that provide foundational and growth capital to emerging companies.

His clients operate in and/or invest in a diverse array of industries, ranging from robotics to the agricultural sciences, artificial intelligence, biotechnology, autonomous vehicles, digital media and beyond.

Prior to joining Cohen & Grigsby, Matt was assistant general counsel and senior investigator at the Mintz Group in New York, a corporate intelligence and investigations firm. Matt began his career in the project finance group at Chadbourne & Parke LLP in New York.

Fred Maroni, INDIGO’s President & CEO, responsible for setting the strategies to achieve profitability, and long term growth. INDIGO Biosciences, a recognized industry-leading provider of nuclear receptor products and services. Large Pharmaceutical and Biotech companies are part of the “who’s who” list of customers that INDIGO services.

Since joining INDIGO Biosciences, the Company has achieved profited in each of its past five (5) years, increase revenue by 150%, over-subscribed a successful fundraise, and relocated its facility. Indigo continues to grow its business through acquisition of technology, expansion of its global footprint and expanding into new markets. Now that the company has reached profitability, market expansion will be the key to long term viability.

Mr. Marroni is a successful entrepreneur with over 25 years of Executive Management and Engineering experience. His experiences span multiple industries, technologies, and organization stages including turn-around management. His attention to details, team motivational skills and operational experience were key factors in achieving 100% revenue growth in several companies. His experiences range from being the founding executive of several companies to senior management of a Fortune 1000 business. He has lead efforts in merger and acquisitions, contract negotiations and over the past 10 years has dedicated his effort to the evaluation and funding of early stage life science companies.

Mr. Marroni’s broad background includes technical development, technology licenses, development of business strategies, funding and regulatory matters. He has played a key role in the formation of eight (8) start-up science companies, six in the area of life sciences. Between 1997 and 2003, he held executive positions with 3 companies that resulted in successful exits.

He holds a B.S. degree in Industrial Engineering from Penn State University and completed an 18-month operational management program.

Maureen co-founded AMI on the entrepreneurial idea that an agile business could solve clinical needs using electronically controlled motion. Over the last 12 years, Maureen built a central Pennsylvania company that develops, manufactures and sells medical devices. By establishing an ‘internal’ start-up ecosystem, her team has the infrastructure to incubate creative ideas and quickly test. Those ideas that demonstrate market potential are developed to commercial exits.

Knowing that FDA cGMP is key to technology valuation, AMI’s process is ISO 13485:2016 certified. To endure the long timelines of medical device regulatory approvals and sales, AMI differentiates from others by using diverse financing model (e.g., SBIRs, sales revenue, Ben Franklin, debt, personal funds and Angel investment). Implementing a stringent hiring process has led to 20 dedicated and engaged team members that apply their skills to multiple projects resulting in 22 issued patents and over 40 pending patent applications, and 3 products generating early revenue.

With the greater visibility, medtech start-ups are coming to AMI for development assistance and/or IP out-licensing. AMI’s capital-efficient location in central Pennsylvania places AMI within driving distance of several top research and clinical facilities, making it possible to forge strong industry relationships. Within Pennsylvania, AMI is partnering with clinicians and researchers at Children’s Hospital of Philadelphia (CHOP), Penn State (PSU)-University Park, PSU-Hershey, PSU Children’s Hospital and University of Pittsburgh.

Maureen has been recognized over 34 times nationally and internationally for her entrepreneurial leadership. In 2017 she was a US delegate to the Global Entrepreneurship Summit in India. Due to her experience growing a start-up, she was appointed to the AdvaMed Accel BOD to represent small emerging medical device companies. She is an alumni of the competitive Goldman Sachs 10,000 Small Business program. Maureen has advanced her CEO leadership skills under instruction of faculty from Babson College and Tuck School of Business of Dartmouth College. She received her Ph.D. from PSU.

Hunter founded Phospholutions, Inc. while completing his undergraduate degree at Penn State University. He graduated from Penn State with a B.S. in Plant Sciences, where he was recognized as Top Entrepreneur within the University. Hunter has been recognized by PA Business Central as Foremost under 40, Top 100 people, and has been featured as a finalist on the WPSU television series The Investment. Hunter sits on the Entrepreneurship and Innovation Advisory Board for the College of Agricultural Sciences at Penn State University.

Steve studied Finance, Economics & Mathematics at the University of Rochester where he built up a real estate investment portfolio with capital from his first online business. He then took a job with Goldman Sachs working on both their technology and real estate research teams. He left Goldman to explore investment opportunities in Madrid Spain later returning to the US to begin work on what would become Ikos with co-founder Patrick Paul. The company has raised $7 million and has nearly 60 employees.

Matt is a partner in the Intellectual Property Group of Reed Smith LLP whose practice covers a breadth of IP issues. He regularly counsels and represents clients in litigation matters, preparation and prosecution of patents and trademarks, portfolio management, and licensing.

Matt has also experienced the client side of Intellectual Property counseling, having been awarded three patents from the USPTO as an engineer before attending law school. Today, Matt handles projects covering a diverse range of technology including chemistry, chemical engineering, pharmaceuticals, environmental engineering, plastics and other specialty materials.

Dennis J. Butler focuses his practice on intellectual property and technology law, including representing clients before the U.S. Patent and Trademark Office and foreign patent offices. Dennis has extensive experience in preparation, filing and prosecution of patent applications as well as inter partes and ex parte reexaminations and reissued patent applications before the U.S. Patent Office. Dennis also has extensive in-person and remote interviews with U.S. patent examiners to expedite allowance of U.S. patents. His practice is concentrated in mechanical technologies, including medical implants, small appliances, automotive mechanisms, cleantech technologies, structural composite assemblies, bicycle technology, indoor games and electro/mechanical devices.

His practice also focuses on patent litigation on behalf of both plaintiffs and defendants. Dennis has experience with preparation and conducting hearings, including claim construction, summary judgment and preliminary injunction hearings, depositions and discovery. He has worked on cases involving a wide variety of technologies, including medical devices, composite materials, firearm accessories, software, business methods and banking processes.

Prior to joining Panitch Schwarze Belisario & Nadel LLP, Dennis was patent counsel at a global medical device company, where he managed their patent portfolio, assisted with patent litigation, formulated business arrangements and analyzed mergers and acquisitions. He was previously an associate and patent agent at Akin Gump Strauss Hauer & Feld LLP and an engineer with Boeing Defense and Space Group, Helicopters Division and United Technologies – Pratt & Whitney.

Dennis received his J.D. from Temple University’s Beasley School of Law while working full-time at Boeing Defense and Space Group and Akin Gump Strauss Hauer & Feld LLP. He was an editor for the Temple Environmental Law and Technology Journal and won the TASA Prize for Outstanding Performance in the Field of Evidence. He received his B.S in Mechanical Engineering Technology and M.S. in Engineering Mechanics from the Pennsylvania State University.

Dennis is a member of the Delaware Bar, the Pennsylvania Bar, the Irish American Business Network and Chamber of Commerce, Penn State Alumni Association and the Nittany Lion Club. He is registered to practice before the U.S. Patent and Trademark Office and is admitted to practice before the U.S. Court of Appeals for the Federal Circuit, U.S. District Court for the District of Delaware, Eastern and Western Districts of Pennsylvania and Supreme Court of Delaware.

Jeff has litigated in federal district court, the U.S. International Trade Commission, Delaware state courts, and before the U.S. Patent and Trademark Office. He also advises startup and early-stage companies on IP and other commercial matters.

Jeff has extensive experience in all aspects of litigation through and including trial. He has litigated cases in federal courts in Delaware, California, Texas, Pennsylvania, and at the International Trade Commission, and has also appeared as lead counsel for his clients in appeals to the Federal Circuit.

In his counseling practice, Jeff assists startup and early-stage companies in developing IP strategies, preparing for and responding to outside threats, and following best practices for protection of business-critical information

Jeff has also helped his clients negotiate complex licensing and settlement deals, in the context of court-assisted mediation and business-to-business transactions. He has drafted and negotiated settlement, licensing, and royalty agreements involving software, patents, and other IP assets.

Jeff regularly represents women and children pro bono in Delaware Family Court. He also represents veterans in appeals to the U.S. Court of Appeals for Veterans Claims. He is a co-founder of the Grafton Street Fund, a charitable organization that seeks out, promotes, and supports innovative and successful non-profit organizations, and is also a charter member of the Delaware Commission on Early Education and the Economy, a group of business leaders that advocates for quality early childhood education in Delaware.

Rachel Herder is the Director of the Penn State Law Intellectual Property (IP) Clinic and an Asst. Prof. of Clinical Law. The IP Clinic is powered by amazing Penn State Law students and provides free legal services to Pennsylvania small businesses and startups, including: patent prosecution and searching; trademark clearance and registration; university licensing, copyright counseling, trade secret counseling, and general IP advice. Before coming to Penn State, Rachel practiced at Wilson Sonsini Goodrich & Rosati, in the firm’s patents and innovation practice in Silicon Valley and Boston. She advised startup life science clients on various aspects of intellectual property law, including patent prosecution and related business strategies especially in the fields of genome editing and gene diagnostics. Rachel holds her Ph.D. in Molecular, Cellular, Developmental Biology & Genetics and J.D. from the University of Minnesota.

Tom Sharbaugh is a Professor of Practice at Penn State Law at the University Park campus of Penn State. He is also the Director of Penn State Law’s Entrepreneur Assistance Clinic (the “EAC”), which is based at the Happy Valley LaunchBox in downtown State College. Using law students who are supervised by Tom and another licensed lawyer, the EAC provides a broad range of business-related legal services to startup and early-stage businesses throughout the Commonwealth of Pennsylvania, including formation of business entities and preparation of agreements among founders, equity compensation arrangements, seed investments and a wide range of operational contracts.

Before joining Penn State Law a few years ago, Tom was a business lawyer in Philadelphia for over 35 years, including almost 15 years as the firm-wide managing partner of operations at Morgan Lewis & Bockius LLP, a global law firm based in Philadelphia and having more than 3,000 personnel. As a partner in the firm's Business & Finance Practice Group, he represented a wide variety of clients in transactional and corporate matters, including private equity funds in M&A and investment transactions. He has a particular interest in start-up and early stage businesses and their funding. He has written a number of articles and delivered many presentations on crowdfunding and the securities laws applicable to capital raising through unregistered offerings.

Tom has other duties with several educational and non-profit institutions. He is the chair of the Penn State Annual Giving Advisory Council, the chair of the President’s Club and a member of the Campaign Executive Committee of Penn State’s current capital campaign, A Greater Penn State for 21st Century Excellence. In addition, he is a member of the Board of Trustees of the Penn Medicine Health System in Philadelphia and the chair of the Board of Managers of the Pennsylvania Hospital in Philadelphia.

Lou Berneman is the founding partner emeritus of OUP, formerly Osage University Partners. OUP invests in startups developing pioneering technologies - across all sectors -- in partnership with the top research institutions in the US and abroad.

Since 2009, OUP has been the most active venture capital investor in university startups. Through a deep relationship with the Technology Transfer Offices (TTOs) of over 100 universities, OUP has backed over 90 of the best and most exciting companies based on university research, which collectively have raised more than $7B in funding. OUP works with entrepreneurs, scientists, and students who are integral to the success of university startup ecosystems. OUP seeks to bring the discoveries of the world’s preeminent researchers to market. OUP has approximately $600M under management and is currently investing out of Fund III -- $273M -- launched in 2019.

Before founding OUP, Lou was managing director of the University of Pennsylvania TTO. He is a past president of the Association of University Technology Managers (AUTM). In “retirement,” Lou serves as an expert witness in intellectual property litigation and has testified in federal and state courts and arbitrations. Lou has a BA from Penn State, a teaching credential from UCSB, and masters and doctoral degrees from Teachers College, Columbia University.

OUP is a venture fund that invests in university start-ups via affiliations with more than 100 academic research institutions in the U.S., Canada, Israel, Singapore, and England. OUP has almost $600 million under management. To date, has invested in more than 90 companies in both life sciences and tech sectors.

Previously, Lou was managing director of UPenn CTT and director of licensing and business development at Virginia’s Center for Innovative Technology. He is a past president of AUTM and former VP and Trustee of LES. He has been involved in licensing, business development, and entrepreneurial activities for 35+ years as a practitioner and educator. He has testified as an expert in intellectual property litigation in federal and state courts and arbitrations.

Lou is a CLP and RTTP. Lou has a BA from Penn State, a teaching credential from UCSB, and masters and doctoral degrees from Teachers College, Columbia University. Texelerate is a tech transfer consultancy. HCR is a private investment fund purchasing royalty interests in commercial and near-commercial stage healthcare products.

Mr. Lubert is the co-founder and Area President of Keiretsu Forum Mid-Atlantic, (K4-MA) the East Coast Region of the world’s largest angel investor network. Members of the Mid-Atlantic Region have invested just over $42m in the last 8 years. He founded the South-East Region of Keiretsu Forum on July 1, 2014 and is currently expanding the Region into Raleigh and Charlotte and is working on expansion into Texas by year’s end.

Howard is the Managing Director of the Rowan Innovation Venture Fund, a university evergreen fund created to kick start the innovation and entrepreneurship ecosystem at Rowan University and the South Jersey Region. Howard brings a distinguished career as serial entrepreneur, private equity and angel investor, mentor and teacher to the Rowan campus.

He is an accredited angel investor and provides early stage and under-performing later stage technology companies with business acceleration services as Managing Partner & Senior Analyst of SafeHatch, the company he spun out of Safeguard Scientifics almost 18 years ago. He is an authority on innovation, business technology trends, and Term Sheets.

His career includes nearly 30 years of technical due diligence for numerous VC, angel, and investment organizations, including Safeguard Scientifics and its family of funds. In addition, he has developed and managed several technology companies.

An expert in technical due diligence, business acceleration, and turn-around business consulting, he got his early training in technology at IBM. He holds a BA in psychology from Moravian College, an MA in school psychology from Glassboro State College, now Rowan University, and received his PhD in Business Administration from Hamilton in 2007. He has extensive teaching and speaking experience in both the technical and private equity areas. He was involved in the development of the Novell Certified Network Engineer (CNE) program, recognized as the first certification program for the networking industry and taught and certified thousands of network engineers. At Keiretsu Howard regularly teaches workshops to entrepreneurs and investors including the Keiretsu Forum Due Diligence Workshop, a half-day deep dive into the most renowned due diligence process in the industry.

He has served as Entrepreneur in Residence for several years at Temple University and West Chester University, and taught in the entrepreneurship major for five years to MBA and undergraduate students at the Fox School of Business at Temple University.

Beth Cohen is the Director of Business Strategy and Innovation and Counsel at Royer Cooper Cohen Braunfeld (RCCB). In her position, Beth helps companies grown by acting as a birdge between the worlds of law and business, using her experience as both a Wharton MBA and an attorney.

She has served as a strategic business development and marketing executive as well as senior legal counsel for US international companies, including in Israel. As a member of the management team for several venture-backed companies, Beth contributed to the profitability of an internet company resulting in an exit; and the double-digit growth of a digital content company's European market. Her current focus is on helping growth stage firms develop strategies to expand their markets and raise capital.

Beth has enjoyed counseling hundreds of companies from around the world and participating as a speaker at many US and international technology conferences. She is proud to have been recognized as one of the top startup lawyers in Philadelphia and to be a recipient of the Wharton Distinguished Alumna Award.

Chris brings more than 20 years of experience raising capital to DC Advisory US and leads the firm’s Private Capital Group. Based in New York, he focuses on growth-stage companies across the Technology, Healthcare, and Business Services sectors. He has closed more than USD 5 billion in private capital raises over the course of his career.

Chris worked for Bear Stearns for nine years and was the head of the private placement group through 2007, when he joined the private placement group at Credit Suisse. He subsequently joined Cantor Fitzgerald to start its private placement group. He also worked in the private placement groups at Bank of America and Prudential Securities.

Chris received an M.B.A. from the Wharton School at the University of Pennsylvania and a B.S. in Finance from the Pennsylvania State University.